UA86807U - Method for correcting impairment of cerebral hemodynamics in patients with chronic obstructive lung diseases - Google Patents
Method for correcting impairment of cerebral hemodynamics in patients with chronic obstructive lung diseasesInfo
- Publication number
- UA86807U UA86807U UAU201308977U UAU201308977U UA86807U UA 86807 U UA86807 U UA 86807U UA U201308977 U UAU201308977 U UA U201308977U UA U201308977 U UAU201308977 U UA U201308977U UA 86807 U UA86807 U UA 86807U
- Authority
- UA
- Ukraine
- Prior art keywords
- impairment
- correcting
- patients
- chronic obstructive
- lung diseases
- Prior art date
Links
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 title abstract 2
- 230000002490 cerebral effect Effects 0.000 title abstract 2
- 230000006735 deficit Effects 0.000 title abstract 2
- 230000000004 hemodynamic effect Effects 0.000 title abstract 2
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 abstract 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 abstract 1
- 229960004352 diosmin Drugs 0.000 abstract 1
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 abstract 1
- 230000001643 venotonic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The method for correcting impairment of the cerebral hemodynamics in the patients with chronic obstructive lung diseases comprises the use of venotonic drug Diosmin at a dose of 600 mg once a day in the morning for 24-48 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201308977U UA86807U (en) | 2013-07-17 | 2013-07-17 | Method for correcting impairment of cerebral hemodynamics in patients with chronic obstructive lung diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201308977U UA86807U (en) | 2013-07-17 | 2013-07-17 | Method for correcting impairment of cerebral hemodynamics in patients with chronic obstructive lung diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA86807U true UA86807U (en) | 2014-01-10 |
Family
ID=52298084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201308977U UA86807U (en) | 2013-07-17 | 2013-07-17 | Method for correcting impairment of cerebral hemodynamics in patients with chronic obstructive lung diseases |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA86807U (en) |
-
2013
- 2013-07-17 UA UAU201308977U patent/UA86807U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX346224B (en) | Compostions and methods for treating chronic inflammation and inflammatory diseases. | |
| PH12015502628A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| MX2015016344A (en) | Imidazopyrrolidinone derivatives and their use in the treatment of disease. | |
| MX2021000538A (en) | Sobetirome in the treatment of myelination diseases. | |
| EP3046603A4 (en) | Fail-safe drug infusion therapy system | |
| MX373716B (en) | PYRAZOL-AMIDE COMPOUND AND ITS PHARMACEUTICAL USES. | |
| MX348831B (en) | Parenteral administration of tapentadol. | |
| WO2014160281A3 (en) | Method of enhancing delivery of therapeutic compounds to the eye | |
| IN2014CN02688A (en) | ||
| EA201301168A1 (en) | ACLIDINE FOR USE IN IMPROVING SLEEP QUALITY IN PATIENTS WITH RESPIRATORY DISEASES | |
| MX366309B (en) | Pharmaceutical composition for treating inflammation and pain. | |
| UA86807U (en) | Method for correcting impairment of cerebral hemodynamics in patients with chronic obstructive lung diseases | |
| MX368641B (en) | Compounds for treating inflammation and pain. | |
| MX2014011922A (en) | Composition for the treatment of inflammatory and immune disorders. | |
| IN2013MU01226A (en) | ||
| HK40106035A (en) | Ophthalmic implant for delivering therapeutic substances | |
| UA91605U (en) | Method for correcting disordered microcirculation in gastric mucosa of aged patients | |
| UA84188U (en) | Method for medical rehabilitation of patients with gastroesophageal reflux disease in setting of chronic obstructive disease of lungs | |
| UA83410U (en) | Method for treatment of patients with chronic pancreatitis with ischemic heart disease at congestive heart failure | |
| UA70124U (en) | Method for correcting endothelial dysfunction in aged patients with ischemic heart disease | |
| UA89638U (en) | Method for treating aged patients with syndrome of vascular cognitive impairment | |
| UA70889U (en) | Method for treating diabetic retinopathy | |
| UA84287U (en) | Method for correcting metabolic disorders in patients with chickenpox | |
| MD4458B1 (en) | Use of Polybiolin drug in patients with liver cirrhosis | |
| UA92326U (en) | Method for correcting antioxidant system in patients with vegetative dystonia with arterial hypertension |